Hexanoate

Hexanoate

SCHEMBL7146845

CCCCCC(=O)O.CCCCOCOC(=O)Nc1ccc2[nH]c(C)c(CCN(C)Cc3cnc4ccccc4n3)c2c1

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1F P30939 1/20 0.38
ALDH1A1 P00352 8/20 0.36
HPGD P15428 3/20 0.36
KDM4E B2RXH2 2/20 0.36
HSD17B10 Q99714 2/20 0.36
MAPT P10636 9/20 0.34
KMT2A Q03164 6/20 0.34
LMNA P02545 4/20 0.34
SERPINE1 P05121 1/20 0.34
HDAC1 Q13547 2/20 0.34
MAPK1 P28482 2/20 0.33
MEN1 O00255 4/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
MOK Q9UQ07 1/20 0.33
ALOX15 P16050 1/20 0.33
NPSR1 Q6W5P4 2/20 0.32
GAA P10253 2/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32
HTT P42858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hexanoate SCHEMBL8550529 0.87 ALDH1A1 (0.33) ALDH1A1HPGDKDM4EHSD17B10MAPT
Hexanoate SCHEMBL8548589 0.87 ACHE (0.33) ALDH1A1HPGDKDM4EHSD17B10MOK
Hexanoate SCHEMBL8190714 0.85 HTR1F (0.39) HTR1FALDH1A1HPGDKDM4EMAPT
Acetic Acid SCHEMBL7142201 0.77 BRD4 (0.43) HTR1FALDH1A1HPGDKDM4EHSD17B10
Hexanoate SCHEMBL8180689 0.77 TLR9 (0.41) ALDH1A1MAPTKMT2AMEN1SMN1; SMN2
Acetic Acid SCHEMBL8192311 0.77 HTR1F (0.42) HTR1FALDH1A1HPGDKDM4EMAPT
Hexanoate SCHEMBL8547899 0.72 GBA1 (0.36) ALDH1A1HPGDKDM4EKMT2ALMNA
Hexanoate SCHEMBL7141372 0.71 KDM4E (0.40) ALDH1A1KDM4EMAPTKMT2ALMNA
SCHEMBL7145980 0.66 HTR1F (0.43) HTR1FALDH1A1MAPTKMT2ALMNA
Benzoic Acid SCHEMBL8191205 0.66 HTR1F (0.45) HTR1FALDH1A1HPGDKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0768301-B1 N-(2-substituted-3-(2-aminoethyl)-1H-indol-5-yl)-amides as new 5-HT1F agonists LILLY CO ELI (US) 2003-04-02 EP disclosed
US-6126932-A INSOLUBLE POLYMER BEARING PENDANT SIDE CHAINS, SAID SIDE CHAINS EACH TERMINATING WITH THE 1-(3-(1-PYRROLIDINYL)-PROPYL)-3-ETHYLCARBODIIMIDE MOIETY. ELI LILLY AND COMPANY (US) 2000-10-03 US disclosed
EP-0994109-A2 1-(3-(1-Pyrrolidinyl)propyl)-3-ethylcarbodiimide and a solid phase coupling agent ELI LILLY AND COMPANY (US) 2000-04-19 EP disclosed
US-5998630-A A 1-(3-(1-PYRROLIDINYL)PROPY)-3-ETHYLCARBODIIMIDE ELI LILLY AND COMPANY (US) 1999-12-07 US disclosed
US-5942536-A USEFUL FOR TREATING MIGRAINE ELI LILLY AND COMPANY (US) 1999-08-24 US disclosed
WO-1997013512-A1 N-[2-SUBSTITUTED-3-(2-AMINOETHYL)-1H-INDOL-5-YL]-AMIDES: NEW 5-HT1F AGONISTS ELI LILLY AND COMPANY (US) 1997-04-17 WO disclosed
EP-0768301-A1 N-(2-substituted-3-(2-aminoethyl)-1H-indol-5-yl)-amides as new 5-HT1F agonists ELI LILLY AND COMPANY (US) 1997-04-16 EP disclosed